[20 years of cardiovascular epidemiology. The clinician's viewpoint].
Over the last twenty years, several important clinical trials have brought major advances in the field of prevention and treatment of cardiovascular diseases. Fibrinolytic drugs, ACE inhibitors, new antiplatelet drugs or new tools in the field of interventional cardiology have been studied and have changed the daily practice of the cardiologists. Several remarks and comments are proposed with regards of these trials.